Gene therapy for haematopoietic and lymphoid disorders

Clinical and Experimental Immunology, Supplement

Volumn 107, Issue SUPPL. 1, 1997, Pages 54-57

  Kohn, D B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Gene delivery vectors; Haematopoietic stem cells

Indexed keywords

CYTOKINE; INTERLEUKIN 3; INTERLEUKIN 6;

CELL PROLIFERATION; CONFERENCE PAPER; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOID CELL; PRIORITY JOURNAL; RETROVIRUS; STEM CELL; UMBILICAL CORD BLOOD;

ANIMALS; GENE THERAPY; GENETIC DISEASES, INBORN; GENETIC VECTORS; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 0031025853     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Parkman R. The application of bone marrow transplantation to the treatment of genetic diseases. Science 1986; 232:1373-78.
2. Anderson WF. Prospects for human gene therapy. Science 1984; 226:401-9.
3. Kohn DB. The current status of gene therapy using hematopoietic stem cells. Current Opinions in Pediatrics 1995; 7(1):56-63.
4. Wolff JA, Lederberg J. An early history of gene transfer and therapy. Hum Gene Ther 1994; 5:469-80.
5. Miller AD. Retroviral vectors. Curr Top Microbiol Immunol 1992; 158:1-24.
6. Williams DA. Expression of introduced genetic sequences in hematopoietic cells following retroviral-mediated gene transfer. Hum Gene Ther 1990; 1:229-39.
7. - progenitor cells. Blood 1991; 77:1218-25.
8. - cells in cord blood and bone marrow. Blood 1995; 86:3745-53.
9. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341:85-6.
10. Deisseroth AB, Zu Z, Claxton D et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83:3068-76.
11. Dunbar CE, Cottler-Fox, M, O'Shaughnessy JA et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85:3048-57.
12. Kohn DB, Weinberg KI, Nolta JA et al. Engraftment of gene-modified cells from umbilical cord blood in neonates with adenosine deaminase deficiency. Nature Medicine 1995; 1:1017-26.
13. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Current Topics in Microbiology and Immunology 1992; 158:97-129.